Last updated on November 2019
A Study to Assess the Safety Tolerability Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
Brief description of study
A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of EDP-305 in subjects with primary biliary cholangitis
Clinical Study Identifier: NCT03394924